News und Analysen
Essential Utilities Q2 Earnings Call Highlights
Key Points
- Interested in Essential Utilities Inc.? Here are five stocks we like better.
- Second-quarter earnings were broadly stable: GAAP EPS was $0.37 versus $0.38 a year earlier, while
Super Group (SGHC) Q2 Earnings Call Highlights
Key Points
- Interested in Super Group (SGHC) Limited? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 18% year over year to $684 million, while adjusted EBITDA
Qiagen Q2 Earnings Call Highlights
Key Points
- Interested in Qiagen N.V.? Here are five stocks we like better.
- Qiagen exceeded its second-quarter outlook, reporting $535 million in sales, flat year over year, and adjusted
PACS Group Q2 Earnings Call Highlights
Key Points
- Interested in PACS Group, Inc.? Here are five stocks we like better.
- PACS Group delivered strong Q2 growth: Revenue rose 9.1% year over year to $1.43 billion, net income increased 50%
Oscar Health Q2 Earnings Call Highlights
Key Points
- Interested in Oscar Health, Inc.? Here are five stocks we like better.
- Oscar Health reported record first-half profitability, including $1.1 billion in operating earnings and $1
Orion Office REIT Q2 Earnings Call Highlights
Key Points
- Interested in Orion Office REIT Inc.? Here are five stocks we like better.
- Orion raised its 2026 outlook, narrowing Core FFO guidance to $0.72–$0.77 per share from $0.69–$0.76, while
Orion Q2 Earnings Call Highlights
Key Points
- Interested in Orion S.A.? Here are five stocks we like better.
- Orion’s Q2 adjusted EBITDA was $58 million, up 26% sequentially but down 15% year over year. The company reaffirmed
Envista Q2 Earnings Call Highlights
Key Points
- Interested in Envista Holdings Corporation? Here are five stocks we like better.
- Strong second-quarter performance: Envista reported $731 million in sales, up just over 7% year over
Haemonetics Q1 Earnings Call Highlights
Key Points
- Interested in Haemonetics Corporation? Here are five stocks we like better.
- Haemonetics raised its fiscal 2027 outlook, now expecting reported revenue growth of 5%–8% and organic
Gerresheimer Aktie: 1,5-Milliarden-Deal mit Apax-Beratung
Zwölf Prozent Kurssprung an einem einzigen Handelstag – so reagierte der Markt Ende Juli…
Der Beitrag Gerresheimer Aktie: 1,5-Milliarden-Deal mit Apax-Beratung erschien zuerst auf kapitalmarktexpert
TriSalus Life Sciences Q2 Earnings Call Highlights
Key Points
- Interested in TriSalus Life Sciences, Inc.? Here are five stocks we like better.
- Revenue rose modestly to $11.4 million in Q2, up 1.7% year over year, while TriSalus reiterated its
Nutex Health Q2 Earnings Call Highlights
Key Points
- Interested in Nutex Health Inc.? Here are five stocks we like better.
- Profitability improved sharply despite lower revenue: Second-quarter revenue fell 13.6% to $210.8 million, but
Sanuwave Health Q2 Earnings Call Highlights
Key Points
- Interested in Sanuwave Health Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 3% year over year to $9.7 million, as a 34% decline in UltraMIST system sales
Scholar Rock Q2 Earnings Call Highlights
Key Points
- Interested in Scholar Rock Holding Corporation? Here are five stocks we like better.
- FDA decision remains on track for Sept. 30: Scholar Rock’s resubmitted application for
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Asklepios Kliniken GmbH & Co. KGaA übermittelt Verlangen zur Durchführung eines Squeeze-out der Minderheitsaktionäre der RHÖN-Klinikum Aktiengesellschaft
EQS-Adhoc: RHÖN-KLINIKUM Aktiengesellschaft: Asklepios Kliniken GmbH & Co. KGaA übermittelt Verlangen zur Durchführung eines Squeeze-out der Minderheitsaktionäre der RHÖN-Klinikum Aktiengesellschaft
Privia Health Group Q2 Earnings Call Highlights
Key Points
- Interested in Privia Health Group, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Privia Health’s implemented providers grew 10.1%, attributed lives increased
The Pennant Group Q2 Earnings Call Highlights
Key Points
- Interested in The Pennant Group, Inc.? Here are five stocks we like better.
- Strong Q2 performance: Revenue rose 35.8% year over year to $298 million, while adjusted EBITDA increased
Praxis Precision Medicines Q2 Earnings Call Highlights
Key Points
- Interested in Praxis Precision Medicines, Inc.? Here are five stocks we like better.
- FDA reviews are progressing for ulixacaltamide and relutrigine, with no advisory committee
Omada Health Q2 Earnings Call Highlights
Omada Health (NASDAQ:OMDA) reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve
Ocugen Q2 Earnings Call Highlights
Ocugen (NASDAQ:OCGN) said its second quarter marked progress across its late-stage ophthalmology pipeline, including FDA clearance to begin a Phase III study of OCU410 in geographic atrophy and an
INmune Bio Q2 Earnings Call Highlights
Key Points
- Interested in INmune Bio, Inc.? Here are five stocks we like better.
- Regulatory and manufacturing progress: INmune Bio plans to seek conditional U.K. approval for Ebstrocel in late
Halozyme Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Halozyme Therapeutics, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 48% year over year to $481 million, while royalty revenue increased
BioMarin Pharmaceutical Q2 Earnings Call Highlights
Key Points
- Interested in BioMarin Pharmaceutical Inc.? Here are five stocks we like better.
- BioMarin’s second-quarter revenue nearly reached $1 billion, rising 20% year over year. The company
Orion Energy Targets $95M-$97M Revenue After Margin Gains at Annual Meeting
Key Points
- Interested in Orion Energy Systems, Inc.? Here are five stocks we like better.
- Fiscal 2026 results improved: Revenue rose to $86.3 million from $79.7 million, gross margin increased
Zillow Group Q2 Earnings Call Highlights
Zillow Group (NASDAQ:Z) reported second-quarter revenue growth that exceeded its outlook, led by gains in its For Sale and